All News Ironwood Pharmaceuticals, Inc.

Equities

IRWD

US46333X1081

Market Closed - Nasdaq Other stock markets 01:30:00 22/06/2024 am IST			5-day change	1st Jan Change
6.09 ^USD	+9.14%		+4.46%	-46.77%

21/06	Ironwood Pharmaceuticals Names Sravan Emany to Additional Role of Chief Operating Officer	MT
10/06	Ironwood Pharmaceuticals Insider Sold Shares Worth $517,694, According to a Recent SEC Filing	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ironwood Pharmaceuticals : Corporate Presentation	22/06	PU
Ironwood Pharmaceuticals Names Sravan Emany to Additional Role of Chief Operating Officer	21/06	MT
Ironwood Pharmaceuticals Insider Sold Shares Worth $517,694, According to a Recent SEC Filing	11/06	MT
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference	31/05	BU
Ironwood Pharmaceuticals Insider Sold Shares Worth $436,136, According to a Recent SEC Filing	23/05	MT
Ironwood Late-Breaker Oral Presentation at Digestive Disease Week Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure	22/05	AQ
Ironwood Pharmaceuticals : Late-Breaker Oral Presentation at Digestive Disease Week®	21/05	PU
Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)	21/05	BU
Ironwood Pharmaceuticals, Inc. Presents Late-Breaking Data During the 2024 Digestive Disease Week Meeting from Its Pivotal Phase III Clinical Trial, STARS	21/05	CI
Sector Update: Health Care Stocks Higher Late Afternoon	10/05	MT
Sector Update: Health Care Stocks Gain in Thursday Afternoon Trading	09/05	MT
Sector Update: Health Care	09/05	MT
Ironwood Pharmaceuticals' Shares Fall After Q1 Swings to a Non-GAAP Loss, Revenue Declines; 2024 Revenue Guidance Cut	09/05	MT
Transcript : Ironwood Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 09, 2024	09/05
Ironwood Pharmaceuticals : 1Q 2024 Investor Update	09/05	PU
(IRWD) IRONWOOD PHARMACEUTICALS Expects Fiscal Year 2024 Revenue Range $405M - $425M	09/05	MT
Earnings Flash (IRWD) IRONWOOD PHARMACEUTICALS Reports Q1 Revenue $74.9M	09/05	MT
Ironwood: Q1 Earnings Snapshot	09/05	AQ
Ironwood Pharmaceuticals, Inc. Revised Earnings Guidance for Its Fiscal Year 2024	09/05	CI
Ironwood Pharmaceuticals Reports First Quarter 2024 Results	09/05	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Ironwood Pharmaceuticals, Inc.

Equities

IRWD

US46333X1081

All News

Filters